Tharimmune Correlations

THAR Stock   4.14  0.21  5.34%   
The current 90-days correlation between Tharimmune and Adlai Nortye Ltd is 0.22 (i.e., Modest diversification). The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tharimmune Correlation With Market

Weak diversification

The correlation between Tharimmune and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tharimmune and DJI in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tharimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Tharimmune Stock, please use our How to Invest in Tharimmune guide.

Moving against Tharimmune Stock

  0.68KURA Kura OncologyPairCorr
  0.65ABP Abpro HoldingsPairCorr
  0.54DWTX Dogwood TherapeuticsPairCorr
  0.35LYRA Lyra TherapeuticsPairCorr
  0.31EDIT Editas MedicinePairCorr
  0.54MREO Mereo BioPharma GroupPairCorr
  0.51PRQR ProQR TherapeuticsPairCorr
  0.5MBIO Mustang BioPairCorr
  0.45BCAX Bicara TherapeuticsPairCorr
  0.36SVRA Savara IncPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MBRXADTX
ADTXGOVX
ADTXICU
AIMDICU
ICUGOVX
MBRXGOVX
  

High negative correlations

APLMGOVX
ADAPBLRX
LNAIANL
APLMBLRX
APLMICU
APLMAIMD

Risk-Adjusted Indicators

There is a big difference between Tharimmune Stock performing well and Tharimmune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tharimmune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BLRX  2.59 (0.27) 0.00 (0.19) 0.00 
 5.20 
 13.04 
GOVX  5.33 (2.41) 0.00 (0.83) 0.00 
 9.38 
 42.89 
ANL  8.59  3.97  0.52 (4.71) 5.41 
 25.00 
 100.98 
LNAI  6.16 (0.03) 0.00  0.15  0.00 
 12.62 
 55.92 
ICU  5.02 (1.17) 0.00 (0.46) 0.00 
 9.58 
 34.66 
ADAP  12.64  0.79  0.03 (0.23) 15.04 
 22.82 
 168.52 
AIMD  4.50 (0.89) 0.00 (0.22) 0.00 
 12.30 
 38.73 
APLM  6.21  0.70  0.10  0.86  6.61 
 17.08 
 44.38 
ADTX  10.14 (2.62) 0.00 (2.01) 0.00 
 22.54 
 63.67 
MBRX  4.68 (1.55) 0.00 (0.88) 0.00 
 9.37 
 41.63 

Tharimmune Corporate Management

Dong KimChief OfficerProfile
Jacob AsburyChief OfficerProfile
Nir MDChief AdvisorProfile
Mark WendlandChief OfficerProfile
Vincent LoPrioreExecutive BoardProfile